Identification and validation of monocyte to macrophage differentiation-associated as a prognostic biomarker in gastric cancer
MMD plays an oncogenic role in gastric cancer. It may serve as a potential biomarker for GC diagnosis and a therapeutic target.
Authors
- Qinghong Guo (ORCID: https://orcid.org/0000-0003-2456-7362)
- Liang Qiao (ORCID: https://orcid.org/0000-0002-6233-8459)
- Suyang Bai (ORCID: https://orcid.org/0000-0002-0046-2702)
- Rui Ji (ORCID: https://orcid.org/0000-0003-4245-4775)
- Yuping Wang (ORCID: https://orcid.org/0000-0002-8676-7549)
- Zhaofeng Chen (ORCID: https://orcid.org/0000-0002-3408-0446)
- Yongning Zhou
Institutions
- Westmead Institute (AU)
- Westmead Institute for Medical Research (AU)
- First Hospital of Lanzhou University (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.3389/fonc.2025.1508355
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Lanzhou University
- National Natural Science Foundation of China
- Science and Technology Program of Gansu Province